Efficacy and Safety of Risankizumab in Paediatric Patients With Psoriasis in the OptIMMize-1 Phase III Study

British Journal of Dermatology · Published 2026-09-26 · Journal article · DOI 10.1093/bjd/ljag403

Authors (15)

Nina Magnolo, Wine Lee Lara, Adam Reich, Irene Lara-Corrales, Akimichi Morita, Michael Bukhalo, Asunción Vicente, Toni Anschutz, Rosie D Lyles, Tshepiso Madihlaba, Kristina Unnebrink, Doug Ashley, Dolly Sharma, Ronilda D’Cunha, Amy S Paller

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Magnolo, N., Lara, W., Reich, A., et al. (2026). Efficacy and Safety of Risankizumab in Paediatric Patients With Psoriasis in the OptIMMize-1 Phase III Study. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljag403

Related articles